Japan
Kyoto University - Department of Pathology and Tumor Biology
Triple negative breast cancer, HRD, microtubule inhibitors, eribulin, response, resistance
COVID-19, pneumonia, phenotype, Cluster Analysis, Japan
Endometrial cancer, Stage IA, Occult tumor spread, Molecular subtypes, Prognosis